ART-Treated Patients Exhibit an Adaptive Immune Response against the HFVAC Peptides, a Potential HIV-1 Therapeutic Vaccine (Provir/Latitude45 Study)

We proposed a new HIV-1 therapeutic vaccine based on conserved cytotoxic T lymphocyte (CTL) epitopes of archived HIV-1 DNA according to their affinity to the dominant HLA-A and -B alleles of the population investigated. Our proposal (Hla Fitted VAC, HFVAC) was composed of 15 peptides originating fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleury, Hervé, Caldato, Sabrina, Recordon-Pinson, Patricia, Thebault, Patricia, Guidicelli, Gwenda-Line, Hessamfar, Mojgan, Morlat, Philippe, Bonnet, Fabrice, Visentin, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694376/
https://www.ncbi.nlm.nih.gov/pubmed/33167335
http://dx.doi.org/10.3390/v12111256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694376/
https://www.ncbi.nlm.nih.gov/pubmed/33167335
http://dx.doi.org/10.3390/v12111256

Ejemplares similares